Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Fairlie

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
Journal of Medicinal Chemistry|February 12, 2000
Protease inhibitors: current status and future prospectsD Leung, G Abbenante, D P Fairlie
Neurobiology of Aging|December 10, 1999
The possible origin of free radicals from amyloid beta peptides in Alzheimer's diseaseA I Bus, X Huang, D P Fairlie
Current Medicinal Chemistry|July 1, 1998
Towards protein surface mimeticsD P Fairlie, M L West, A K Wong
Chemico-Biological Interactions|July 1, 1980
cis-Platinum(II) amine complexes: some structure-activity relationships for immunosuppressive, nephrotoxic and gastrointestinal (side) effects in ratsJ A Broomhead, D P Fairlie, M W Whitehouse
Idrugs : the Investigational Drugs Journal|August 30, 2005
Development of C5a receptor antagonistsA K Wong, S M Taylor, D P Fairlie
Chemico-Biological Interactions|March 1, 1987
Irritancy and anti-inflammatory activity of bis(eta 5-cyclopentadienyl)titanium(IV) complexes in ratsD P Fairlie, M W Whitehouse, J A Broomhead
Medical Hypotheses|May 3, 2000
Cell phenotype as a target of drug therapy in chronic inflammatory diseasesI A Shiels, S M Taylor, D P Fairlie
Biochemical and Biophysical Research Communications|October 30, 1992
Flavones are inhibitors of HIV-1 proteinaseR I Brinkworth, M J Stoermer, D P Fairlie
Biochemistry|September 16, 1998
Solution structure of methionine-oxidized amyloid beta-peptide (1-40). Does oxidation affect conformational switching?A A Watson, D P Fairlie, D J Craik
Agents and Actions|May 1, 1992
Zinc monoglycerolate--a slow-release source of therapeutic zinc: solubilization by endogenous ligandsD P Fairlie, M W Whitehouse, R M Taylor
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
Journal of Medicinal Chemistry|February 12, 2000
Protease inhibitors: current status and future prospectsD Leung, G Abbenante, D P Fairlie
Neurobiology of Aging|December 10, 1999
The possible origin of free radicals from amyloid beta peptides in Alzheimer's diseaseA I Bus, X Huang, D P Fairlie
Current Medicinal Chemistry|July 1, 1998
Towards protein surface mimeticsD P Fairlie, M L West, A K Wong
Chemico-Biological Interactions|July 1, 1980
cis-Platinum(II) amine complexes: some structure-activity relationships for immunosuppressive, nephrotoxic and gastrointestinal (side) effects in ratsJ A Broomhead, D P Fairlie, M W Whitehouse
Idrugs : the Investigational Drugs Journal|August 30, 2005
Development of C5a receptor antagonistsA K Wong, S M Taylor, D P Fairlie
Chemico-Biological Interactions|March 1, 1987
Irritancy and anti-inflammatory activity of bis(eta 5-cyclopentadienyl)titanium(IV) complexes in ratsD P Fairlie, M W Whitehouse, J A Broomhead
Medical Hypotheses|May 3, 2000
Cell phenotype as a target of drug therapy in chronic inflammatory diseasesI A Shiels, S M Taylor, D P Fairlie
Biochemical and Biophysical Research Communications|October 30, 1992
Flavones are inhibitors of HIV-1 proteinaseR I Brinkworth, M J Stoermer, D P Fairlie
Biochemistry|September 16, 1998
Solution structure of methionine-oxidized amyloid beta-peptide (1-40). Does oxidation affect conformational switching?A A Watson, D P Fairlie, D J Craik
Agents and Actions|May 1, 1992
Zinc monoglycerolate--a slow-release source of therapeutic zinc: solubilization by endogenous ligandsD P Fairlie, M W Whitehouse, R M Taylor
Pageof 8